Mr. Mikhail Blagosklonny is a specialist who studies aging and cancer. He is also a lecturer of Oncology at RPCI (Roswell Park Cancer Institute). Mikhail Blagosklonny attended St. Peterburg Medical University, from where he received his medical degree in internal medicine. He also received his Ph.D. in cardiology and experimental medicine from the same institution. In 2002, Mikhail was an associate professor of medicine at NYMC (New York Medical College). He also worked as a senior scientist at Ordway Research Institute. Mr. Mikhail Blagosklonny has enough skills and experience to become an excellent professor and scientist. He has also done a lot of research in various areas including cancer, anti-aging drugs, cancer therapy, and biogerontology. In that case, Mr. Mikhail always carry out his research studies with the objective of finding medical solutions to cancer and aging patients. Read more on templeofthecave.com
Currently, Mr. Mikhail Blagosklonny is the Chief Editor of Cell Cycle and Oncotarget. Most of his written works are about cancer biology and therapy. He is also an editorial board member of Cell Death and Differentiation. He came up with the hypothesis regarding the potential role of TOR Signaling in aging and cancer treatment. He also proposed the use of Rapamycin, which is a popular drug for cancer treatment. He is one of the passionate supporters of Rapamycin in the longevity research. The research includes clinical investigations and molecular and cellular biology. In addition to cellular and molecular biology, longevity research includes mitosis, tumor suppressors, ontogenesis, signal transduction, anticancer therapeutics, apoptosis, and cell cycle.
Mr. Mikhail Blagosklonny is also an author of many books and articles. He is the author of the hyperfunction theory, chemotherapeutic engineering, and cell cyclotherapy. Mikhail Blagosklonny has a keen interest in oncology and understands that it is possible to control cancer and aging using Rapamycin. Mr. Mikhail is a hardworking and committed scientist who has contributed a lot to the research involving cancer treatment. Mikhail’s love for humanity has made him one of the biggest Oncologists in the world. He always has the vision of ensuring that his community is disease-free. View Mikhail’s profile on Google Scholar
Additionally, Mr. Mikhail is the Founder of Oncotarget, which is one of the traditional multidisciplinary journal with free access. It publishes online papers on weekly issues, and each paper can be printed in case of a special demand. The mission of Oncotarget is to make scientific information and results widely and rapidly available. The idea is to maximize the effect of research through insightful reviews.